Collectively, our data strongly suggest that high PRMT3 expression was negatively correlated with the abundance of T cell infiltration and strongly associated with poor prognosis and poor response to immunotherapy in HCC patients. Here, PRMT3 is linked to hepatocellular carcinoma.